NASDAQ:CRDF

Cardiff Oncology Earning Date

USA |NASDAQ |USD

CRDF Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $-0.17 $-0.17 $-0.19
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $30.00K $68.00K $136.40K

Cardiff Oncology's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

CRDF Earnings Date & History Chart

CRDF Earnings & Revenue Forecast

CRDF Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-0.18 $-0.20 $-0.16
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-0.66 $-0.71 $-0.62
Dec 2022 4 $-0.92 $-1.15 $-0.68

CRDF Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.18 $-0.17 $-0.18
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.66 $-0.64 $-0.64
Dec 2022 0 / 0 $-0.92 $-1.02 $-1.01

CRDF Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 4 $30.00K $0.00 $70.00K
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $200.00K $140.00K $280.00K
Dec 2022 4 $150.00K $0.00 $400.00K

CRDF Earnings Date & Revenue History

CRDF Earnings History

|
Show More
Show More

CRDF Revenue History

|
Show More
Show More

Cardiff Oncology Next Earnings Date & Report

CRDF Next Earnings Date & Report Preview: Sep 2021 (FQ)

CRDF's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 4 analysts, the average EPS estimation for Cardiff Oncology's next quarterly earnings is $-0.17, with a low EPS estimation of $-0.19, and a high estimation of $-0.15.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.17, the last 2 month trend is $-0.17, and the 3 month trend is $-0.17.

Based on 4 analysts, the average revenue estimation is $30.00K, with a low revenue estimation of $0.00, and a high estimation of $70.00K.

Cardiff Oncology Previous Earnings Dates & Reports

CRDF Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Cardiff Oncology's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.

CRDF's earnings per share (EPS) was $-0.17, missing the consensus analysts forecast of $-0.15 by -13.33%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 21.43%, and higher than the same period a year before (Jun 2020) by -66.67%.

Revenues were $68.00K, worse than the forecast of $150.00K by -54.67%, down by -5.56% from the previous quarter , and up by 59.50% from the same period last year.

The company reported a net income of $-6.76M.

Free cash flow for the quarter was $-4.30M , compared to $-5.88M last quarter and $-4.29M a year before.

CRDF ended the quarter with $408.00K in total debt, a decrease of -36.55% compared to the previous quarter, and an increase of 33.77% compared to the same quarter a year before.

CRDF Previous Earnings Date & Report Recap: Dec 2020 (FY)

Cardiff Oncology's previous annual earnings date was Feb 25, 2021 for its fiscal year ended Dec 31, 2020.

CRDF's earnings per share (EPS) was $-1.19, missing the consensus analysts forecast of $-1.09 by 9.17% , and higher than the previous year's EPS (Dec 2019) by -60.73%.

Revenues were $365.99K, worse than the forecast of $366.00K by -0.00%, and up by 49.61% from previous year's revenue.

The company reported a net income of $-19.31M.

Cardiff Oncology reported a free cash flow of $-16.53M for its fiscal year, compared to $-13.34M a year ago.

The company ended the fiscal year with $869.50K in total debt, a decrease of -49.63% compared to the previous year.